These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38017515)

  • 1. Effects of Lianhuaqingwen Capsules in adults with mild-to-moderate coronavirus disease 2019: an international, multicenter, double-blind, randomized controlled trial.
    Zheng JP; Ling Y; Jiang LS; Mootsikapun P; Lu HZ; Chayakulkeeree M; Zhang LX; Arttawejkul P; Hu FY; Truong TNL; Perez RA; Gu X; Sun HM; Jiang JJ; Liu RJ; Ding Z; Zhan YQ; Yang ZF; Guan WJ; Zhong NS
    Virol J; 2023 Nov; 20(1):277. PubMed ID: 38017515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of Lianhua Qingwen capsules combined with standard of care in the treatment of adult patients with mild to moderate COVID-19 (FLOSAN): protocol for a randomized, double-blind, international multicenter clinical trial.
    Zhan YQ; Chen RF; Zheng QS; Li XW; Liu YN; Mootsikapun P; Chayakulkeeree M; Arttawejkul P; Lan TTN; Liu GG; Lu HZ; Liu QQ; Zhong NS; Yang ZF; Zheng JP
    J Thorac Dis; 2023 May; 15(5):2859-2872. PubMed ID: 37324081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trial.
    Hu K; Guan WJ; Bi Y; Zhang W; Li L; Zhang B; Liu Q; Song Y; Li X; Duan Z; Zheng Q; Yang Z; Liang J; Han M; Ruan L; Wu C; Zhang Y; Jia ZH; Zhong NS
    Phytomedicine; 2021 May; 85():153242. PubMed ID: 33867046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of Reduqing granules in the treatment of common cold with wind-heat syndrome: a randomized, double-blind, double-dummy, positive-controlled trial.
    Ma Y; Zhang Z; Wei L; He S; Deng X; Ji A; Zhou B; Jiang D; Li M; Wang Y
    J Tradit Chin Med; 2017 Apr; 37(2):185-92. PubMed ID: 29960290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chinese herbal medicine Shufeng Jiedu capsule for mild to moderate COVID-19: a multicenter, randomized, double-blind, placebo-controlled phase II trial.
    Lu CL; Yang LQ; Jin XY; Friedemann T; Li YF; Liu XH; Chen XY; Zou XY; Zhang BR; Wang FX; Lin YL; Tang YM; Cao ML; Jiang YL; Gao YF; Liu K; Tao ZG; Robinson N; Schröder S; Liu JP; Lu HZ
    Front Pharmacol; 2024; 15():1383831. PubMed ID: 38863976
    [No Abstract]   [Full Text] [Related]  

  • 8. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
    Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
    Trials; 2021 May; 22(1):343. PubMed ID: 34001215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leritrelvir for the treatment of mild or moderate COVID-19 without co-administered ritonavir: a multicentre randomised, double-blind, placebo-controlled phase 3 trial.
    Zhan Y; Lin Z; Liang J; Sun R; Li Y; Lin B; Ge F; Lin L; Lu H; Su L; Xiang T; Pan H; Huang C; Deng Y; Wang F; Xu R; Chen D; Zhang P; Tong J; Wang X; Meng Q; Zheng Z; Ou S; Guo X; Yao H; Yu T; Li W; Zhang Y; Jiang M; Fang Z; Song Y; Chen R; Luo J; Kang C; Liang S; Li H; ; Zheng J; Zhong N; Yang Z
    EClinicalMedicine; 2024 Jan; 67():102359. PubMed ID: 38188690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive effects of Lianhuaqingwen granules in COVID-19 patients: A retrospective study of 248 cases.
    Shen P; Li J; Tu S; Wu Y; Peng Y; Chen G; Chen C
    J Ethnopharmacol; 2021 Oct; 278():114220. PubMed ID: 34029640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multi-center, randomized controlled trial by the Integrative Management in Japan for Epidemic Disease (IMJEDI study-RCT) on the use of Kampo medicine, kakkonto with shosaikotokakikyosekko, in mild-to-moderate COVID-19 patients for symptomatic relief and prevention of severe stage: a structured summary of a study protocol for a randomized controlled trial.
    Takayama S; Namiki T; Ito T; Arita R; Nakae H; Kobayashi S; Yoshino T; Ishigami T; Tanaka K; Kainuma M; Nochioka K; Takagi A; Mimura M; Yamaguchi T; Ishii T
    Trials; 2020 Oct; 21(1):827. PubMed ID: 33008479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase 2/3 study of S-217622 in participants with SARS-CoV-2 infection (Phase 3 part).
    Yotsuyanagi H; Ohmagari N; Doi Y; Imamura T; Sonoyama T; Ichihashi G; Sanaki T; Tsuge Y; Uehara T; Mukae H
    Medicine (Baltimore); 2023 Feb; 102(8):e33024. PubMed ID: 36827007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of lianhuaqingwen granules in the management of chronic rhinosinusitis without nasal polyps.
    Lin L; Dai F; Ren G; Wei J; Chen Z; Tang X
    Am J Otolaryngol; 2020; 41(1):102311. PubMed ID: 31732300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural herbal medicine Lianhuaqingwen capsule anti-influenza A (H1N1) trial: a randomized, double blind, positive controlled clinical trial.
    Duan ZP; Jia ZH; Zhang J; Liu S; Chen Y; Liang LC; Zhang CQ; Zhang Z; Sun Y; Zhang SQ; Wang YY; Wu YL
    Chin Med J (Engl); 2011 Sep; 124(18):2925-33. PubMed ID: 22040504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Lianhua Qingwen on viral shedding in omicron mild/asymtomatic patients: a real-world study.
    Gai X; Yan C; Wu C; Duan Z; Fan J; Yuan S; Yang P; Bao F; Jing H; Cai C; Ma Y; Zhang W; Sun Y
    Front Med (Lausanne); 2024; 11():1357299. PubMed ID: 38596791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Traditional Chinese Medicine, Maxingshigan-Weijing in the management of COVID-19 patients with severe acute respiratory syndrome: A structured summary of a study protocol for a randomized controlled trial.
    Zeng C; Yuan Z; Pan X; Zhang J; Zhu J; Zhou F; Shan Z; Yuan Y; Ye R; Cheng J
    Trials; 2020 Dec; 21(1):1029. PubMed ID: 33357239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Lianhua Qingwen for children with SARS-CoV-2 Omicron infection: A propensity score-matched retrospective cohort study.
    Xu X; Wu H; Jin G; Huang J; Li J; Zhou J; Cao M; Sun D; Zhang W; Peng W; Pu Y; Chen C; Sun Y; Yang H; Zhou S; Fang B
    Phytomedicine; 2023 Mar; 111():154665. PubMed ID: 36641977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of combined therapy of qingfeiPaidu capsule and lianhuaqingwen capsule nursing interventions for hospitalized patients with COVID-19: A retrospective study of medical records.
    Li Y; Yu W; Zhai J; Wang K; Huo H; Du Z
    Medicine (Baltimore); 2022 Aug; 101(32):e29964. PubMed ID: 35960047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.